Tag Archives: Therasense

Supreme Court Will Not Review Therasense Standards – Yet

On October 15, 2013, after reviewing the Government’s Amicus Brief (a copy is available at the end of this post), the Supreme Court denied the petition for cert. filed by Sony Computer Entertainment, one of the defendants in 1st Media, … Continue reading

Posted in Inequitable Conduct/Rule 56 | Tagged , , , , , , , , , , , | Leave a comment

Top Ten Biotech IP Stories of 2012

I admit, I am a sucker for lists, esp. Top Ten Lists, and a few days ago, sat through a half hour of “local news” wherein the anchors breathlessly related the Top Ten Rhode Island News Stories of 2012. Well, … Continue reading

Posted in Miscellaneous | Tagged , , , , , , , , , , , | 2 Comments

In re Rosuvastatin Calcium Patent Litigation – Making “Therasense” out of Confusion

Recently, a divided three judge panel sorting out a multi-party Hatch-Waxman suit, ruled that the patentee, Shinonogi, had not committed inequitable conduct in obtaining the patent that was subsequently reissued so as to obtain narrow claims focused on Rosuvastatin, or … Continue reading

Posted in Inequitable Conduct/Rule 56, Reissue | Tagged , , , , , , , , , , , , , , , , | 1 Comment

1st Media, LLC v. Electronic Arts, Inc. – Specific Intent Means Specific Intent

On September 13th, the Fed. Cir. reversed a district court ruling that the inventor and the attorney who prosecuted a chain of applications claimed multi-media entertainment systems had committed inequitable conduct by failing to disclose three “relevant” references at various … Continue reading

Posted in Inequitable Conduct/Rule 56 | Tagged , , , , | Leave a comment